To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DNASE2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
364 supporting clones for gene DNASE2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC319361 brain .a 1 to 574 1 to 574   tiling clone,   574/574
(100 %)
0 diff
(100 %id)
DC385307 rectum .a 21 to 495 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
BX394955 Neuroblastoma Cot 25-normalized .a 24 to 1098 1 to 1071       1071/1079
(99 %)
21 diff
(98.1 %id)
DC352986 brain .a 27 to 590 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DC398071 testis .a 27 to 597 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC305729 cerebellum .a 55 to 527 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
DA900966   .a 64 to 712 2 to 654   capped   653/658
(99 %)
8 diff
(98.8 %id)
AL711078 human skeletal muscle .a 75 to 641 1 to 567       567/567
(100 %)
0 diff
(100 %id)
NM_001375.2   .a 75 to 2085 1 to 2011 exact RefSeq,   2011/2011
(100 %)
2 diff
(100.0 %id)
DA255964 caudate nucleus .a 76 to 621 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AU099937   .a 89 to 388 1 to 300       300/300
(100 %)
5 diff
(98.4 %id)
BP273423   .a 89 to 644 1 to 556       556/556
(100 %)
5 diff
(99.2 %id)
BP339931 Spleen .a 89 to 668 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB032263 testis .a 90 to 628 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
AU121810 mammary gland .a 91 to 857 2 to 770   capped   769/786
(97 %)
6 diff
(99.3 %id)
BP323978 Pancreas .a 91 to 672 1 to 582       582/583
(99 %)
8 diff
(98.7 %id)
DA691118   .a 92 to 668 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA839647 placenta .a 92 to 636 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CB123374 Liver .a 98 to 771 1 to 674       674/674
(100 %)
3 diff
(99.6 %id)
TI_57163745   .a 101 to 1052 53 to 994       940/1020
(92 %)
17 diff
(98.4 %id)
BP213604 cerebrum .a 105 to 673 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
BG284871 adenocarcinoma, cell line, Prostate .a 108 to 595 1 to 481       481/481
(100 %)
9 diff
(98.2 %id)
BP277688   .a 109 to 689 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA843759 placenta .a 109 to 679 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
N39729 melanocyte .a 110 to 482 1 to 370       370/370
(100 %)
8 diff
(97.9 %id)
BM829383 Ascites, stomach .a 111 to 771 1 to 661       661/661
(100 %)
4 diff
(99.4 %id)
DC300577   .a 112 to 589 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
BP252264 Kidney .a 112 to 686 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
N39745 melanocyte .a 112 to 465 1 to 350       350/350
(100 %)
8 diff
(97.8 %id)
BM825969 Ascites, stomach .a 112 to 490 1 to 379       379/379
(100 %)
0 diff
(100 %id)
DC413651 ovary, tumor tissue .a 112 to 564 1 to 454       454/454
(100 %)
2 diff
(99.6 %id)
DA053035   .a 113 to 638 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA287220 corpus callosum .a 113 to 663 2 to 552   capped   551/551
(100 %)
4 diff
(99.3 %id)
DA361829 subthalamic nucleus .a 113 to 661 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DA689497   .a 113 to 667 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA819524   .a 113 to 669 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA826580 pericardium .a 113 to 681 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA840287 placenta .a 113 to 668 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA845196 placenta .a 113 to 680 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA879209 Prostate .a 113 to 677 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA964949 stomach .a 113 to 689 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
DA968503 stomach .a 113 to 628 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DB105207 thymus .a 113 to 663 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB116815 thymus .a 113 to 652 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB007490 cervix, tumor tissue .a 114 to 669 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BP196410 adrenal gland .a 116 to 697 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP382609 adipose tissue .a 116 to 736 1 to 621       621/621
(100 %)
3 diff
(99.6 %id)
BP382610 adipose tissue .a 116 to 741 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
DC360438   .a 116 to 586 1 to 473       473/473
(100 %)
2 diff
(99.6 %id)
DA630414 Kidney .a 116 to 692 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DC371925   .a 116 to 525 1 to 412       412/412
(100 %)
2 diff
(99.6 %id)
BM828780 Ascites, stomach .a 116 to 233 1 to 118       118/118
(100 %)
3 diff
(97.5 %id)
DA002791   .a 117 to 671 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA004221   .a 117 to 622 2 to 507   capped   506/508
(99 %)
1 diff
(99.9 %id)
DA008523 adipose .a 117 to 624 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA014528 adrenal gland .a 117 to 638 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA016139 adrenal gland .a 117 to 624 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
DA039864 bladder .a 117 to 624 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DA089905 cerebellum .a 117 to 624 2 to 510   capped   509/509
(100 %)
2 diff
(99.7 %id)
DA133862 alzheimer cortex .a 117 to 674 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA198939 brain .a 117 to 686 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA566891 heart .a 117 to 675 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA595818 lung .a 117 to 638 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA612523   .a 117 to 628 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA633292 Kidney .a 117 to 702 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA692030   .a 117 to 679 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA692600   .a 117 to 685 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA920672 small intestine .a 117 to 672 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA945899 Spleen .a 117 to 678 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DA968420 stomach .a 117 to 638 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA998066   .a 117 to 638 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DB102265 thymus .a 117 to 669 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB242955 stomach, tumor tissue .a 117 to 680 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BI834283 pooled pancreas and spleen .a 118 to 1052 1 to 926       924/952
(97 %)
11 diff
(98.9 %id)
DC381045 placenta .a 118 to 443 1 to 326       326/326
(100 %)
0 diff
(100 %id)
BP341524 stomach mucosa .a 118 to 699 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP342421 stomach mucosa .a 118 to 699 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA826890 pericardium .a 119 to 676 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA167973 amygdala .a 121 to 678 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
BP252555 Kidney .a 122 to 705 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BG469211 adenocarcinoma cell line, colon .a 122 to 780 1 to 666       666/667
(99 %)
10 diff
(98.6 %id)
BP373612 umbilical cord .a 122 to 704 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP376313 uterus .a 122 to 703 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA008332 adipose .a 123 to 685 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA045012 bladder .a 123 to 686 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA555701   .a 123 to 677 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BG822224 adenocarcinoma cell line, colon .a 123 to 999 1 to 871       871/937
(92 %)
17 diff
(98.2 %id)
DA626482 Kidney .a 123 to 691 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
CN312168 embryonic stem cells, DMSO-treated H9 cellline .a 124 to 345 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
T53394 placenta .a 124 to 435 1 to 312       312/318
(98 %)
8 diff
(97.5 %id)
W24597 lung .a 124 to 259 1 to 136       136/136
(100 %)
7 diff
(94.9 %id)
BG831793 epithelioid carcinoma cell line, Pancreas .a 127 to 1058 1 to 924       924/996
(92 %)
40 diff
(96.0 %id)
DA962123 Spleen .a 127 to 683 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB189719 lung, tumor tissue .a 127 to 562 2 to 437   capped   436/436
(100 %)
1 diff
(99.8 %id)
AF060222   .a 128 to 2082 1 to 1955 exact tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1955/1955
(100 %)
0 diff
(100 %id)
CF141049 CNCAP(3)T-225 cell line, Prostate .a 129 to 614 1 to 486       486/486
(100 %)
6 diff
(98.8 %id)
BM051430 eye, normal pigmented retinal epithelium .a 129 to 835 1 to 715       715/987
(72 %)
19 diff
(98.1 %id)
BC065209 Eye, retinoblastoma .a 130 to 1883 1 to 1754 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1754/1754
(100 %)
0 diff
(100 %id)
CN312170 embryonic stem cells, DMSO-treated H9 cellline .a 130 to 425 13 to 308       296/308
(96 %)
6 diff
(98.1 %id)
BP419569 small intestine .a 130 to 623 9 to 502     Submitted on the opposite strand 494/502
(98 %)
6 diff
(98.9 %id)
BP307021   .a 130 to 708 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CR983498 T-Lymphocytes .a 130 to 768 1 to 639       639/639
(100 %)
0 diff
(100 %id)
CR978941 T-Lymphocytes .a 130 to 810 1 to 681       681/681
(100 %)
0 diff
(100 %id)
BQ678764 melanotic melanoma, cell line, skin .a 131 to 927 1 to 811       811/984
(82 %)
17 diff
(98.3 %id)
BM465274 eye, retinoblastoma .a 132 to 828 1 to 703       703/1024
(68 %)
8 diff
(99.3 %id)
AK315358   .a 133 to 1303 1 to 1171 exact     1171/1171
(100 %)
1 diff
(100.0 %id)
AA224257 brain, neuroepithelial cells .a 133 to 569 1 to 437       437/454
(96 %)
16 diff
(96.5 %id)
BG283546 adenocarcinoma, cell line, Prostate .a 133 to 929 1 to 792       792/1167
(67 %)
20 diff
(98.3 %id)
DA999386 breast, tumor tissue .a 133 to 668 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
TI_154171701   .a 133 to 726 77 to 673       597/901
(66 %)
15 diff
(98.4 %id)
DA037917   .a 134 to 701 2 to 569   capped   568/569
(99 %)
2 diff
(99.7 %id)
CR617284 Neuroblastoma Cot 25-normalized .a 135 to 1724 1 to 1590 exact     1590/1590
(100 %)
0 diff
(100 %id)
BX393647 Neuroblastoma Cot 10-normalized .a 135 to 1011 1 to 874       874/874
(100 %)
23 diff
(97.4 %id)
AL526369 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 135 to 846 1 to 711   fully sequenced,   711/711
(100 %)
1 diff
(99.9 %id)
BX419019 brain, fetal brain .a 135 to 1134 1 to 985       985/997
(98 %)
20 diff
(98.0 %id)
AA218787 brain, neuroepithelial cells .a 137 to 474 1 to 334       334/334
(100 %)
9 diff
(97.4 %id)
DB008063 cervix, tumor tissue .a 141 to 685 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DB044880 testis .a 141 to 479 2 to 340   capped   339/345
(98 %)
1 diff
(99.8 %id)
DA977007 synovial membrane tissue from rheumatioidarthritis .a 142 to 628 2 to 488   capped   487/487
(100 %)
1 diff
(99.8 %id)
BG423740 Kidney, renal cell adenocarcinoma .a 143 to 913 1 to 775       775/939
(82 %)
16 diff
(98.3 %id)
AF045937   .a 145 to 1895 1 to 1751 exact     1751/1751
(100 %)
0 diff
(100 %id)
BP382732 adipose tissue .a 146 to 756 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
DB465158 hippocampus .a 146 to 581 1 to 436       436/436
(100 %)
10 diff
(97.8 %id)
DA599386   .a 146 to 719 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP254461 Kidney .a 147 to 711 1 to 566       566/572
(98 %)
24 diff
(95.9 %id)
BF569267 Kidney, renal carcinoma (ascites) .a 147 to 853 1 to 709       709/709
(100 %)
5 diff
(99.3 %id)
BP292108 lung .a 147 to 717 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
BP296649   .a 147 to 728 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP298075   .a 147 to 700 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BP298312   .a 147 to 727 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP301770   .a 147 to 728 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP305549   .a 147 to 698 1 to 554       554/580
(95 %)
29 diff
(95.0 %id)
BP306668   .a 147 to 728 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP329764 rectum .a 147 to 736 1 to 592       592/597
(99 %)
9 diff
(98.5 %id)
BM789197 stomach .a 147 to 812 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
DA074126 cerebellum .a 148 to 722 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AL554064 placenta, Placenta Cot 25-normalized .a 148 to 1091 1 to 941   fully sequenced,   941/941
(100 %)
11 diff
(98.9 %id)
DA464178   .a 148 to 707 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA466825 cord Blood .a 148 to 712 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BP255381 Kidney .a 148 to 726 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BP294777   .a 148 to 747 1 to 600       600/600
(100 %)
4 diff
(99.4 %id)
DA688709   .a 148 to 687 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA819098   .a 148 to 703 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA823542 pericardium .a 148 to 690 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA846690 placenta .a 148 to 717 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA891420 rectum .a 148 to 638 2 to 493   capped   492/492
(100 %)
2 diff
(99.6 %id)
DB003030 breast, tumor tissue .a 148 to 688 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB193616 ovary, tumor tissue .a 148 to 719 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AU142788   .a 148 to 909 2 to 764   capped   763/763
(100 %)
8 diff
(99.0 %id)
AB004574   .a 149 to 1742 1 to 1593 exact     1593/1593
(100 %)
2 diff
(99.9 %id)
AF047016   .a 149 to 2068 1 to 1920 exact     1920/1920
(100 %)
7 diff
(99.7 %id)
CR605842 adult brain .a 149 to 1782 1 to 1634 exact     1634/1634
(100 %)
0 diff
(100 %id)
CR608424 Placenta Cot 25-normalized .a 149 to 1883 1 to 1735 exact     1735/1735
(100 %)
0 diff
(100 %id)
BX386266 Placenta Cot 25-normalized .a 149 to 1125 1 to 970       970/979
(99 %)
10 diff
(99.0 %id)
AL532880 adult brain, brain .a 149 to 1150 1 to 996       996/1032
(96 %)
16 diff
(98.5 %id)
BI764607 pooled colon, kidney, stomach .a 149 to 898 1 to 751       751/751
(100 %)
4 diff
(99.5 %id)
CV804426 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 149 to 789 1 to 641       641/642
(99 %)
1 diff
(99.9 %id)
DR157701 human embryonic stem cells differentiated toan early endodermal cell type .a 149 to 779 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BX417174 placenta .a 151 to 1104 1 to 948       948/982
(96 %)
16 diff
(98.4 %id)
TI_57152713   .a 151 to 898 66 to 814       749/814
(92 %)
8 diff
(99.1 %id)
BF983473 duodenal adenocarcinoma, cell line, small intestine .a 155 to 732 37 to 614       578/888
(65 %)
10 diff
(98.9 %id)
CB125943 cervix, Uterine .a 156 to 623 1 to 468       468/468
(100 %)
18 diff
(96.2 %id)
BP382455 adipose tissue .a 157 to 784 1 to 628       628/629
(99 %)
2 diff
(99.7 %id)
BF342813 brain, glioblastoma with EGFR amplification .a 158 to 882 1 to 725       725/879
(82 %)
26 diff
(97.1 %id)
BP223230 colon mucosa .a 159 to 791 1 to 629       629/633
(99 %)
26 diff
(95.9 %id)
BI223912 cervical carcinoma cell line, cervix .a 159 to 929 1 to 782       782/784
(99 %)
28 diff
(96.5 %id)
BP304860   .a 159 to 730 1 to 569       569/583
(97 %)
26 diff
(95.6 %id)
DA847954 placenta .a 159 to 730 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AK075449 placenta .a 160 to 1883 1 to 1724 Q106L     1724/1724
(100 %)
4 diff
(99.8 %id)
BX283158 lymph, lymphoma, cell line .a 160 to 668 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BP227118   .a 160 to 741 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP296075   .a 160 to 732 1 to 575       575/586
(98 %)
12 diff
(98.0 %id)
BP296513   .a 160 to 740 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP296524   .a 160 to 744 1 to 585       585/585
(100 %)
6 diff
(99.0 %id)
BP297116   .a 160 to 732 1 to 573       573/576
(99 %)
2 diff
(99.7 %id)
BP299982   .a 160 to 740 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP304183   .a 160 to 740 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP305874   .a 160 to 739 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
DN996885 breast cancer, Mammary gland (cancer tissue) .a 160 to 898 8 to 746       739/746
(99 %)
2 diff
(99.8 %id)
DA004562   .a 161 to 746 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA038589   .a 161 to 714 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA049652   .a 161 to 679 2 to 521   capped   520/520
(100 %)
2 diff
(99.7 %id)
DA419279 cord Blood .a 161 to 704 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA539998 lung .a 161 to 605 2 to 446   capped   445/445
(100 %)
0 diff
(100 %id)
BU849575 ovary, teratocarcinoma, cell line .a 161 to 1025 1 to 876       876/878
(99 %)
17 diff
(98.1 %id)
DA647407 mammary gland .a 161 to 1052 2 to 912   capped   911/913
(99 %)
35 diff
(96.2 %id)
DA681396 ovary .a 161 to 720 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA830869 placenta .a 161 to 852 2 to 701   capped   700/706
(99 %)
14 diff
(98.1 %id)
DA846570 placenta .a 161 to 706 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA982393 synovial membrane tissue from rheumatioidarthritis .a 161 to 654 2 to 496   capped   495/495
(100 %)
2 diff
(99.6 %id)
DB000600 breast, tumor tissue .a 161 to 696 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DB001781 breast, tumor tissue .a 161 to 693 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BQ056128 lymph, lymphoma, cell line .a 162 to 1020 1 to 871       871/989
(88 %)
19 diff
(98.1 %id)
BQ058023 lymph, lymphoma, cell line .a 162 to 1135 1 to 979       979/1005
(97 %)
18 diff
(98.3 %id)
BQ064287 lymph, lymphoma, cell line .a 162 to 1029 1 to 877       877/960
(91 %)
12 diff
(98.8 %id)
BQ064813 lymph, lymphoma, cell line .a 162 to 1101 1 to 958       958/1010
(94 %)
9 diff
(99.2 %id)
CF127422 Chondrosarcoma Lung Metastasis cell lines, lung .a 162 to 953 1 to 789       789/789
(100 %)
5 diff
(99.4 %id)
BP304708   .a 162 to 711 1 to 554       554/566
(97 %)
19 diff
(96.7 %id)
TI_154192828   .a 162 to 990 51 to 874       824/990
(83 %)
11 diff
(98.9 %id)
BP303057   .a 163 to 718 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CR978541 T-Lymphocytes .a 163 to 929 1 to 768       768/777
(98 %)
2 diff
(99.8 %id)
CT000261 T-Lymphocytes .a 163 to 369 1 to 207       207/207
(100 %)
0 diff
(100 %id)
BI254718 cervical carcinoma cell line, cervix .a 164 to 806 1 to 646       646/646
(100 %)
3 diff
(99.6 %id)
BU543891 carcinoma, cell line, Prostate .a 164 to 1044 1 to 885       885/894
(98 %)
3 diff
(99.7 %id)
CX753576 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 164 to 926 1 to 752     Submitted on the opposite strand 752/752
(100 %)
15 diff
(98.1 %id)
CX759047 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 164 to 897 1 to 734     Submitted on the opposite strand 734/734
(100 %)
1 diff
(99.9 %id)
AL544758 placenta, Placenta Cot 25-normalized .a 169 to 1075 36 to 931       896/931
(96 %)
53 diff
(94.4 %id)
BX324816 Placenta Cot 25-normalized .a 173 to 1272 1 to 1088       1088/1088
(100 %)
30 diff
(97.3 %id)
CR612006 Neuroblastoma Cot 25-normalized .a 176 to 1709 1 to 1534 exact     1534/1534
(100 %)
0 diff
(100 %id)
AL527366 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 176 to 1060 1 to 883       883/883
(100 %)
5 diff
(99.5 %id)
BF980796 duodenal adenocarcinoma, cell line, small intestine .a 178 to 891 1 to 725       725/1067
(67 %)
18 diff
(98.4 %id)
DA988399 synovial membrane tissue from rheumatioidarthritis .a 179 to 730 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
BP306619   .a 180 to 758 1 to 579       579/582
(99 %)
3 diff
(99.5 %id)
DA046393 bladder .a 181 to 743 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BP301498   .a 187 to 548 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
BP302943   .a 187 to 767 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DA367003 subthalamic nucleus .a 190 to 635 2 to 449   capped   448/448
(100 %)
2 diff
(99.6 %id)
BP264866 muscle .a 190 to 630 1 to 441       441/443
(99 %)
4 diff
(99.1 %id)
DB005968 breast, tumor tissue .a 190 to 730 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DB192968 ovary, tumor tissue .a 190 to 718 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
AL555190 placenta .a 192 to 960 1 to 768   fully sequenced,   768/768
(100 %)
5 diff
(99.4 %id)
DA466112   .a 192 to 755 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA985915 synovial membrane tissue from rheumatioidarthritis .a 192 to 764 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
CR616269 HeLa cells Cot 25-normalized .a 193 to 1694 1 to 1502 exact     1502/1502
(100 %)
0 diff
(100 %id)
BF307918 muscle, rhabdomyosarcoma .a 196 to 929 1 to 727       727/835
(87 %)
18 diff
(97.9 %id)
BF305912 muscle, rhabdomyosarcoma .a 196 to 929 1 to 726       726/880
(82 %)
12 diff
(98.7 %id)
BC010419 Muscle, rhabdomyosarcoma .a 197 to 1716 1 to 1521 exact available from MGC, AAA   1521/1521
(100 %)
2 diff
(99.9 %id)
BP305587   .a 197 to 826 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
CN312171 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 207 to 763 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CN312169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 213 to 824 1 to 612       612/612
(100 %)
6 diff
(99.1 %id)
BE294178 muscle, rhabdomyosarcoma .a 216 to 818 1 to 605       605/606
(99 %)
3 diff
(99.6 %id)
AW860330 colon .a 220 to 636 420 to 5       416/420
(99 %)
0 diff
(100 %id)
BT007047   .a 221 to 1302 1 to 1082       1082/1083
(99 %)
1 diff
(100.0 %id)
CA455309 adenocarcinoma, cell line, breast .a 221 to 977 1 to 768       768/871
(88 %)
10 diff
(98.9 %id)
AW674859 cervix .a 223 to 481 1 to 259       259/322
(80 %)
30 diff
(90.7 %id)
BE908777 epithelioid carcinoma, Pancreas .a 224 to 460 1 to 236       236/261
(90 %)
5 diff
(98.1 %id)
BE250172 muscle, rhabdomyosarcoma .a 235 to 1088 1 to 872       677/953
(71 %)
38 diff
(96.1 %id)
BE296744 muscle, rhabdomyosarcoma .a 235 to 935 1 to 706       706/728
(96 %)
12 diff
(98.4 %id)
BM791775 stomach .a 235 to 874 1 to 640       640/640
(100 %)
2 diff
(99.7 %id)
BE297212 muscle, rhabdomyosarcoma .a 236 to 928 1 to 726       618/763
(80 %)
50 diff
(93.5 %id)
FJ752529 Liver .a 269 to 1335 1 to 1067       1067/1067
(100 %)
4 diff
(99.7 %id)
CA489694   .a 301 to 945 10 to 666       665/882
(75 %)
24 diff
(97.3 %id)
BQ882916 brain, neuroblastoma, cell line .a 315 to 1174 1 to 863       863/863
(100 %)
6 diff
(99.4 %id)
BY996722   .a 323 to 1014 9 to 701       694/701
(99 %)
6 diff
(99.2 %id)
BF312433 brain, neuroblastoma .a 353 to 995 1 to 640   AAA   640/851
(75 %)
11 diff
(98.8 %id)
AA075967 Pancreas .a 364 to 765 1 to 400       400/400
(100 %)
7 diff
(98.3 %id)
BX411487 adult brain, brain .a 397 to 1329 929 to 1       929/929
(100 %)
22 diff
(97.7 %id)
CA942885 Pancreas, Purified pancreatic islet .a 402 to 946 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
CD108536 brain, Pituitary .a 407 to 1273 1 to 870       870/870
(100 %)
8 diff
(99.1 %id)
BQ423994 eye, retinoblastoma .a 409 to 1191 12 to 802       791/921
(85 %)
18 diff
(98.1 %id)
BM479449 duodenal adenocarcinoma, cell line, small intestine .a 424 to 1315 1 to 910       910/1120
(81 %)
14 diff
(98.8 %id)
AI908512 breast .a 506 to 1026 15 to 534       520/544
(95 %)
8 diff
(98.6 %id)
AA359692 lung .a 518 to 801 1 to 284       284/284
(100 %)
1 diff
(99.7 %id)
AW959701   .a 519 to 926 1 to 410       410/432
(94 %)
16 diff
(96.3 %id)
CF146152 CNCAP(3)T-225 cell line, Prostate .a 554 to 1245 7 to 699       693/699
(99 %)
3 diff
(99.6 %id)
TI_154178536   .a 554 to 1430 72 to 945       874/874
(100 %)
17 diff
(98.1 %id)
CK001601 brain/CNS, Bulk tissue from Human Spinal cord .a 578 to 1184 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
BG422998 Kidney, renal cell adenocarcinoma .a 582 to 1185 1 to 602       602/605
(99 %)
6 diff
(99.1 %id)
AA559942 Prostate, prostatic intraepithelial neoplasia - highgrade .a 600 to 929 27 to 357       331/362
(91 %)
8 diff
(97.8 %id)
BE743893 adenocarcinoma cell line, ovary .a 603 to 1442 1 to 843       843/1001
(84 %)
20 diff
(98.1 %id)
BP295895   .a 609 to 1202 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BY994620   .a 616 to 1267 4 to 655       652/655
(99 %)
6 diff
(99.1 %id)
BM761074 lymph node, stomach .a 623 to 1270 1 to 648       648/648
(100 %)
0 diff
(100 %id)
BM842805 lymph node, stomach .a 623 to 1209 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BM850159 lymph node, stomach .a 623 to 1340 1 to 718       718/718
(100 %)
0 diff
(100 %id)
BM831622 lymph node, stomach .a 624 to 1152 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
CF144958 CNCAP(3)T-225 cell line, Prostate .a 665 to 1121 8 to 464       457/464
(98 %)
8 diff
(98.3 %id)
TI_154177084   .a 665 to 1271 76 to 689       614/1009
(60 %)
18 diff
(98.3 %id)
CD105944 brain, Pituitary .a 681 to 1547 1 to 869       869/869
(100 %)
3 diff
(99.7 %id)
BX345768 Placenta Cot 25-normalized .a 687 to 1199 125 to 632       508/667
(76 %)
27 diff
(96.0 %id)
AA419060 ovarian tumor, ovary .a 687 to 1106 1 to 419   fully sequenced,   419/419
(100 %)
2 diff
(99.6 %id)
BQ695101 adipose .a 698 to 1315 1 to 614       614/614
(100 %)
8 diff
(98.7 %id)
CD516609 White Matter .a 703 to 1530 1 to 831       831/835
(99 %)
8 diff
(99.1 %id)
AL526553 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 816 to 1724 909 to 1   fully sequenced,   909/909
(100 %)
1 diff
(99.9 %id)
AL555189 placenta .a 899 to 1694 799 to 1   fully sequenced,   799/799
(100 %)
12 diff
(98.5 %id)
BM504316 insulinoma, Pancreas .a 922 to 1300 1 to 379       379/379
(100 %)
6 diff
(98.5 %id)
BM309918 insulinoma, Pancreas .a 929 to 1300 8 to 379       372/379
(98 %)
6 diff
(98.5 %id)
CK905451 insulinoma, Pancreas .a 929 to 1310 8 to 389       382/389
(98 %)
6 diff
(98.5 %id)
BF570238 Kidney, renal carcinoma (ascites) .a 950 to 1690 759 to 1       759/835
(90 %)
35 diff
(95.9 %id)
BQ671424 epidermoid carcinoma, cell line, salivary gland .a 980 to 1904 12 to 946       935/951
(98 %)
33 diff
(96.6 %id)
AL570779 placenta, Placenta Cot 25-normalized .a 982 to 1890 911 to 1     Submitted on the opposite strand 911/976
(93 %)
21 diff
(97.9 %id)
BM853782 Ascites, stomach .a 985 to 1356 1 to 372       372/372
(100 %)
0 diff
(100 %id)
AI955785 adenocarcinoma, Pancreas .a 995 to 1575 582 to 1       582/582
(100 %)
3 diff
(99.5 %id)
BG777813 adenocarcinoma, Prostate .a 1011 to 1684 1 to 674       674/675
(99 %)
8 diff
(98.9 %id)
T71530 Liver .a 1017 to 1350 5 to 348       344/381
(90 %)
5 diff
(98.7 %id)
AA658098   .a 1018 to 1396 1 to 377       377/377
(100 %)
19 diff
(95.0 %id)
CN312173 embryonic stem cells, cell lines H1, H7, andH9 .a 1019 to 1606 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
TI_154125967   .a 1028 to 1736 785 to 79   AAA   707/910
(77 %)
10 diff
(99.0 %id)
H12842 placenta .a 1030 to 1465 1 to 446       446/446
(100 %)
17 diff
(96.2 %id)
H01754 placenta .a 1030 to 1283 1 to 260   fully sequenced,   260/260
(100 %)
4 diff
(98.5 %id)
BQ446087 Knee, Osteoarthritic Cartilage .a 1050 to 1736 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
CA309756 Alveolar Macrophage, lung .a 1050 to 1736 705 to 19   AAA   687/687
(100 %)
1 diff
(99.9 %id)
CA748717 Alveolar Macrophage, lung .a 1052 to 1736 700 to 16   AAA   685/685
(100 %)
0 diff
(100 %id)
AL576890 placenta, Placenta Cot 25-normalized .a 1061 to 2045 981 to 1   fully sequenced,   981/981
(100 %)
26 diff
(97.4 %id)
AL532829 adult brain, brain .a 1064 to 2050 985 to 1       985/988
(99 %)
11 diff
(98.9 %id)
CN312167 embryonic stem cells, DMSO-treated H9 cellline .a 1073 to 1777 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
AA419087 ovarian tumor, ovary .a 1083 to 1576 492 to 1   fully sequenced,   492/492
(100 %)
4 diff
(99.2 %id)
BF036462 adenocarcinoma, ovary .a 1099 to 1616 1 to 516       516/516
(100 %)
7 diff
(98.7 %id)
CA416251 Chondrosarcoma Cell line .a 1113 to 1736 641 to 19   AAA   623/623
(100 %)
3 diff
(99.6 %id)
AI524395 lymph node, lymphoma, follicular mixed small and largecell .a 1115 to 1575 464 to 1       464/464
(100 %)
10 diff
(97.9 %id)
BQ772674 Chondrosarcoma Cell line .a 1125 to 1736 629 to 19   AAA   611/611
(100 %)
2 diff
(99.7 %id)
CA407149 adipose .a 1151 to 1648 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
AI914998 ovary, tumor, 5 pooled (see description) .a 1157 to 1553 403 to 1       403/403
(100 %)
14 diff
(96.6 %id)
BF968859 adrenal cortex carcinoma, cell line, adrenal gland .a 1158 to 1883 14 to 737   AAA   724/746
(97 %)
7 diff
(99.1 %id)
CA942644 Pancreas, Purified pancreatic islet .a 1160 to 1743 592 to 9       584/592
(98 %)
0 diff
(100 %id)
AI581882 colon .a 1175 to 1729 558 to 1       558/560
(99 %)
18 diff
(96.8 %id)
AI983645 adenocarcinoma, Pancreas .a 1183 to 1918 735 to 1       735/737
(99 %)
19 diff
(97.5 %id)
AA304430 aorta .a 1211 to 1473 1 to 263       263/263
(100 %)
1 diff
(99.7 %id)
H01008 placenta .a 1253 to 1575 334 to 1   fully sequenced,   334/334
(100 %)
12 diff
(96.5 %id)
BM995228 Chondrosarcoma, Left Pubic Bone .a 1253 to 1901 649 to 1       649/649
(100 %)
0 diff
(100 %id)
CA442988 Fibrosarcoma .a 1257 to 1915 677 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 659/659
(100 %)
9 diff
(98.7 %id)
TI_154108415   .a 1266 to 2082 870 to 62   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 809/940
(86 %)
11 diff
(98.9 %id)
W76065 heart .a 1300 to 1592 1 to 304   fully sequenced,   304/304
(100 %)
17 diff
(94.5 %id)
DB362292 mammary gland .a 1348 to 1907 559 to 1       559/562
(99 %)
13 diff
(97.7 %id)
CA447617 Chondrosarcoma, Left Pelvis .a 1350 to 2082 751 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 733/738
(99 %)
0 diff
(100 %id)
T71367 Liver .a 1367 to 1723 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
AI623519 adenocarcinoma, Pancreas .a 1369 to 1737 370 to 2       369/370
(99 %)
0 diff
(100 %id)
AA227224 brain, neuroepithelial cells .a 1375 to 1737 363 to 1       363/363
(100 %)
0 diff
(100 %id)
DB376233 placenta .a 1384 to 1880 498 to 3       496/498
(99 %)
0 diff
(100 %id)
T39552 placenta .a 1394 to 1660 1 to 268   fully sequenced,   268/268
(100 %)
1 diff
(99.7 %id)
T39561 placenta .a 1394 to 1685 1 to 293       293/293
(100 %)
1 diff
(99.7 %id)
T39569 placenta .a 1394 to 1662 1 to 270   fully sequenced,   270/270
(100 %)
1 diff
(99.7 %id)
N42916 melanocyte .a 1430 to 1927 1 to 501       501/507
(98 %)
8 diff
(98.5 %id)
BU858511 mixed (pool of 40 RNAs) .a 1430 to 1924 1 to 497       497/526
(94 %)
7 diff
(98.7 %id)
AI573162 adenocarcinoma, Pancreas .a 1442 to 1890 451 to 3       449/451
(99 %)
0 diff
(100 %id)
AI587090 adenocarcinoma, Pancreas .a 1443 to 1891 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AI500596 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1451 to 1737 287 to 1       287/287
(100 %)
0 diff
(100 %id)
BE250459 muscle, rhabdomyosarcoma .a 1456 to 1815 376 to 3       637/675
(94 %)
19 diff
(97.2 %id)
AA076130 Pancreas .a 1483 to 1916 434 to 1       434/434
(100 %)
10 diff
(97.7 %id)
AI921326 adenocarcinoma, Pancreas .a 1491 to 1907 417 to 1       417/417
(100 %)
0 diff
(100 %id)
BX340176 Placenta Cot 25-normalized .a 1493 to 2083 53 to 643   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 591/643
(91 %)
6 diff
(99.1 %id)
BX330341 Placenta Cot 25-normalized .a 1511 to 2077 570 to 3     Submitted on the opposite strand 568/967
(58 %)
0 diff
(100 %id)
AA931628 carcinoid, lung .a 1516 to 1920 406 to 2       405/406
(99 %)
0 diff
(100 %id)
AA780145   .a 1517 to 1920 407 to 4       404/407
(99 %)
0 diff
(100 %id)
AU147557 mammary gland .a 1527 to 2083 553 to 1       553/553
(100 %)
8 diff
(98.6 %id)
CD369032 Alveolar Macrophage, lung .a 1554 to 1918 382 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 364/364
(100 %)
3 diff
(99.2 %id)
W72508 heart .a 1562 to 1924 369 to 1   fully sequenced,   369/369
(100 %)
4 diff
(99.0 %id)
BE049412 adenocarcinoma, Pancreas .a 1569 to 1891 323 to 1       323/323
(100 %)
0 diff
(100 %id)
DB384252   .a 1573 to 2085 516 to 1   tiling clone,   516/521
(99 %)
22 diff
(95.8 %id)
AI279402 borderline ovarian carcinoma, ovary .a 1574 to 1918 367 to 23   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 345/345
(100 %)
4 diff
(98.9 %id)
BU540255 mixed (pool of 40 RNAs) .a 1631 to 1917 1 to 287       287/323
(88 %)
2 diff
(99.4 %id)
T40665 placenta .a 1632 to 1908 277 to 1   fully sequenced,   277/277
(100 %)
0 diff
(100 %id)
BX324815 Placenta Cot 25-normalized .a 1634 to 2034 441 to 39     Submitted on the opposite strand 403/655
(61 %)
0 diff
(100 %id)
T40662 placenta .a 1644 to 1903 265 to 5   fully sequenced,   261/265
(98 %)
0 diff
(100 %id)
AA541399 colon .a 1648 to 1920 275 to 3       273/275
(99 %)
0 diff
(100 %id)
BG283119 adenocarcinoma, cell line, Prostate .a 1683 to 2083 1 to 401   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 401/401
(100 %)
10 diff
(97.6 %id)
N95196 lung .a 1704 to 2084 387 to 8       380/387
(98 %)
0 diff
(100 %id)
AA634233 lung .a 1716 to 2038 323 to 1       323/323
(100 %)
0 diff
(100 %id)
BP305750   .a 1723 to 2083 1 to 362   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 362/362
(100 %)
1 diff
(99.8 %id)
AA651616 normal prostate, Prostate .a 1747 to 1918 202 to 31   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 172/172
(100 %)
0 diff
(100 %id)
AA663937 lung .a 1785 to 2083 322 to 24   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 299/299
(100 %)
0 diff
(100 %id)
AI431461 lymph node, lymphoma, follicular mixed small and largecell .a 1829 to 2084 258 to 3       256/258
(99 %)
0 diff
(100 %id)
AI433995 adenocarcinoma, Pancreas .a 1880 to 2083 230 to 27   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 204/204
(100 %)
5 diff
(97.6 %id)
CR989160 T-Lymphocytes .b 1 to 735 4 to 738   tiling clone,   738/746
(98 %)
1 diff
(99.9 %id)
AA171437   .b 14 to 437 1 to 427       427/434
(98 %)
22 diff
(95.0 %id)
AK297493 brain .b 15 to 1051 1 to 1037 exact tiling clone,   1037/1037
(100 %)
0 diff
(100 %id)
DC352244 brain .b 15 to 554 1 to 540       540/540
(100 %)
0 diff
(100 %id)
AA169753   .b 891 to 1438 547 to 1   tiling clone,   547/549
(99 %)
1 diff
(99.9 %id)
CX783932 human embryonic stem cells .c 1 to 727 1 to 727 exact tiling clone,   727/727
(100 %)
0 diff
(100 %id)
AL562883 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 128 to 1079 952 to 1       952/963
(98 %)
22 diff
(97.8 %id)
BM466882 eye, retinoblastoma .c 145 to 821 6 to 687       682/1145
(59 %)
14 diff
(98.8 %id)
BG677666 skin, squamous cell carcinoma .c 157 to 958 1 to 810       810/811
(99 %)
15 diff
(98.2 %id)
CK429618 eye, lacrimal gland .c 157 to 759 1 to 603       603/603
(100 %)
0 diff
(100 %id)
AA187467   .c 173 to 371 1 to 200       200/200
(100 %)
3 diff
(98.5 %id)
AA419140 ovarian tumor, ovary .c 181 to 377 1 to 197       197/197
(100 %)
0 diff
(100 %id)
BQ355391 head_neck .c 215 to 862 1 to 648       648/651
(99 %)
15 diff
(97.7 %id)
EL949047 eyeball .c 224 to 703 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
BX505997   .c 244 to 812 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BX386265 Placenta Cot 25-normalized .c 263 to 1253 986 to 1   tiling clone,   986/986
(100 %)
6 diff
(99.4 %id)
AA419141 ovarian tumor, ovary .c 630 to 946 316 to 1       316/316
(100 %)
3 diff
(99.1 %id)
AA187624   .c 914 to 1290 387 to 4   tiling clone,   384/394
(97 %)
0 diff
(100 %id)
BG623296 placenta .d 1 to 750 1 to 769   tiling clone,   769/932
(82 %)
49 diff
(94.8 %id)
BG824310 adenocarcinoma cell line, colon .d 3 to 919 1 to 974   tiling clone,   510/1163
(43 %)
65 diff
(94.5 %id)
CN312172 embryonic stem cells, cell lines H1, H7, andH9 .d 532 to 1244 7 to 717   tiling clone,   715/717
(99 %)
6 diff
(99.2 %id)
AW610362 stomach .e 1 to 383 297 to 678 W118G N119T S120A S121A I122S ... tiling clone,   382/722
(52 %)
12 diff
(98.4 %id)
AW610372 stomach .e 1 to 373 281 to 652   tiling clone,   372/653
(56 %)
14 diff
(97.9 %id)
AK311145 alzheimer cortex Gene DNASE2, variant not shown         Suspected internal deletion, this clone was ignored    
DA137323 alzheimer cortex Gene DNASE2, variant not shown       capped Suspected internal deletion, this clone was ignored    
BX104107 lung Gene DNASE2, variant not shown         This clone was ignored    
AA995641 carcinoid, lung Gene DNASE2, variant not shown         This clone was ignored    
AI078540   Gene DNASE2, variant not shown         Suspected internal deletion, this clone was ignored    
BU177200 melanotic melanoma, skin Gene DNASE2, variant not shown         Suspected internal deletion, this clone was ignored    
BY996066   Gene DNASE2, variant not shown         This clone was ignored    
AV764353 bone marrow Gene DNASE2, variant not shown         Suspected internal deletion, this clone was ignored    
DB008782 cervix, tumor tissue Gene DNASE2, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI